눈물관 캐뉼라 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 설계별, 게이지 크기별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026년-2033년)

Lacrimal Cannula Market Summary

The global lacrimal cannula market size was valued at USD 21.0 million in 2025 and is projected to grow from USD 22.4 million in 2026 to USD 36.7 million by 2033, at a CAGR of 7.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 34.5% in 2025. The rising burden of lacrimal drainage disorders, including nasolacrimal duct obstruction, canalicular stenosis, chronic dacryocystitis, and congenital tear duct obstruction, is driving demand for lacrimal cannulas.

These disorders can impair normal tear drainage and cause symptoms such as excessive tearing, recurrent eye infections, irritation, and inflammation. Diagnosis requires assessment of the lacrimal drainage pathway to identify the location and extent of obstruction. Lacrimal irrigation and probing are commonly used for this purpose, with cannulas enabling controlled delivery of saline or other fluids through the canalicular system. In some cases, these procedures are also performed as part of therapeutic management to restore or evaluate drainage. Ophthalmologists manage a broader range of acquired and congenital lacrimal conditions, and the need for specialized instruments for examination and treatment increases. This supports the consumption of lacrimal cannulas across hospitals and ophthalmic clinics.

For instance, data published by the American Academy of Ophthalmology in 2025 indicate that epiphora is a very common complaint and that nasolacrimal duct obstruction (NLDO) is the most common cause of persistent epiphora. The incidence of NLDO is reported as 20.24 per 100,000. In this incidence study, NDLO accounted for 31.8% of all chronic epiphora and 67.6% of all tear drainage pathway obstructions.

The expansion of specialty eye-care infrastructure is supporting the market by increasing access to hospitals, dedicated ophthalmology centers, ambulatory surgical facilities, and subspecialty services for diagnosing and treating lacrimal drainage disorders. As more healthcare facilities develop capabilities in oculoplastic and lacrimal care, the number of settings performing procedures such as lacrimal irrigation, probing, nasolacrimal duct assessment, and canalicular interventions continues to expand. Lacrimal irrigation requires specialized cannulas to deliver saline in a controlled manner through the canalicular system, making these instruments an important component of lacrimal diagnostic practice. The development of specialized eye-care infrastructure also improves access to trained ophthalmologists and dedicated surgical teams, supporting the use of precision instruments. Expansion across emerging healthcare markets creates additional opportunities for manufacturers to supply reusable and disposable cannulas in different gauges, lengths, and configurations. As specialty facilities expand their diagnostic and surgical capabilities, the addressable base of healthcare providers using lacrimal cannulas also broadens, supporting market demand.

Global Lacrimal Cannula Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global lacrimal cannula market report based on product, design, gauge size, application, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Reusable Lacrimal Cannulas
• Disposable Lacrimal Cannulas
• Design Outlook (Revenue, USD Million, 2021 - 2033)
• Straight
• Curved
• Gauge Size Outlook (Revenue, USD Million, 2021 - 2033)
• 19G-21G
• 22G-24G
• 25G-27G
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Lacrimal Irrigation
• Obstruction Management
• Lacrimal Surgery & Repair
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ophthalmic Clinics & Eye Centers
• Ambulatory Surgical Centers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Argentina
  • Brazil
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Design
  • 1.1.3. Gauge Size
  • 1.1.4. Application
  • 1.1.5. End Use
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Lacrimal Cannula Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of lacrimal drainage disorders
    • 3.2.1.2. Increasing diagnostic evaluation of tear drainage
    • 3.2.1.3. Growing pediatric ophthalmology service availability
    • 3.2.1.4. Expansion of specialized lacrimal surgical procedures
    • 3.2.1.5. Demand for precision-designed ophthalmic instruments
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Limited awareness of specialized lacrimal procedures
    • 3.2.2.2. Low procedural volumes in smaller facilities
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Development of advanced ergonomic cannula designs
    • 3.2.3.2. Expansion of ambulatory ophthalmic surgery centers
    • 3.2.3.3. Growing demand for single-use sterile cannulas
    • 3.2.3.4. Development of pediatric-specific lacrimal cannula designs
    • 3.2.3.5. Increasing adoption of minimally invasive techniques
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Navigating delicate and narrow anatomical pathways
    • 3.2.4.2. Ensuring consistent cannula tip performance
• 3.3. Lacrimal Cannula Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Lacrimal Cannula Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Lacrimal Cannula Market: Product Movement Analysis & Market Share, 2021 & 2033
• 4.3. Reusable Lacrimal Cannulas
  • 4.3.1. Reusable Lacrimal Cannulas Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Disposable Lacrimal Cannulas
    • 4.3.2.1. Disposable Lacrimal Cannulas Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Lacrimal Cannula Market: Design Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Lacrimal Cannula Market: Design Movement Analysis & Market Share, 2021 & 2033
• 5.3. Straight
  • 5.3.1. Straight Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Curved
  • 5.4.1. Curved Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Lacrimal Cannula Market: Gauge Size Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Lacrimal Cannula Market: Gauge Size Movement Analysis & Market Share, 2021 & 2033
• 6.3. 19G-21G
  • 6.3.1. 19G-21G Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. 22G-24G
  • 6.4.1. 22G-24G Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. 25G-27G
  • 6.5.1. 25G-27G Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Lacrimal Cannula Market: Application Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Lacrimal Cannula Market: Application Movement Analysis & Market Share, 2021 & 2033
• 7.3. Lacrimal Irrigation
  • 7.3.1. Lacrimal Irrigation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.4. Obstruction Management
  • 7.4.1. Obstruction Management Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Lacrimal Surgery & Repair
  • 7.5.1. Lacrimal Surgery & Repair Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Lacrimal Cannula Market: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Lacrimal Cannula Market: End Use Movement Analysis & Market Share, 2021 & 2033
• 8.3. Hospitals
  • 8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.4. Ophthalmic Clinics & Eye Centers
  • 8.4.1. Ophthalmic Clinics & Eye Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Ambulatory Surgical Centers
  • 8.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Others
  • 8.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Lacrimal Cannula Market: Regional Estimates & Trend Analysis

• 9.1. Regional Outlook
• 9.2. Lacrimal Cannula Market: Regional Movement Analysis & Market Share, 2021 & 2033
• 9.3. North America
  • 9.3.1. North America Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Competitive Scenario
    • 9.3.2.3. Regulatory Scenario
    • 9.3.2.4. Reimbursement Scenario
    • 9.3.2.5. U.S. Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Competitive Scenario
    • 9.3.3.3. Regulatory Scenario
    • 9.3.3.4. Reimbursement Scenario
    • 9.3.3.5. Canada Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Competitive Scenario
    • 9.3.4.3. Regulatory Scenario
    • 9.3.4.4. Reimbursement Scenario
    • 9.3.4.5. Mexico Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Competitive Scenario
    • 9.4.2.3. Regulatory Scenario
    • 9.4.2.4. Reimbursement Scenario
    • 9.4.2.5. UK Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Competitive Scenario
    • 9.4.3.3. Regulatory Scenario
    • 9.4.3.4. Reimbursement Scenario
    • 9.4.3.5. Germany Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Competitive Scenario
    • 9.4.4.3. Regulatory Scenario
    • 9.4.4.4. Reimbursement Scenario
    • 9.4.4.5. France Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Competitive Scenario
    • 9.4.5.3. Regulatory Scenario
    • 9.4.5.4. Reimbursement Scenario
    • 9.4.5.5. Italy Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Competitive Scenario
    • 9.4.6.3. Regulatory Scenario
    • 9.4.6.4. Reimbursement Scenario
    • 9.4.6.5. Spain Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Competitive Scenario
    • 9.4.7.3. Regulatory Scenario
    • 9.4.7.4. Reimbursement Scenario
    • 9.4.7.5. Denmark Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Competitive Scenario
    • 9.4.8.3. Regulatory Scenario
    • 9.4.8.4. Reimbursement Scenario
    • 9.4.8.5. Sweden Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Competitive Scenario
    • 9.4.9.3. Regulatory Scenario
    • 9.4.9.4. Reimbursement Scenario
    • 9.4.9.5. Norway Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competitive Scenario
    • 9.5.2.3. Regulatory Scenario
    • 9.5.2.4. Reimbursement Scenario
    • 9.5.2.5. Japan Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competitive Scenario
    • 9.5.3.3. Regulatory Scenario
    • 9.5.3.4. Reimbursement Scenario
    • 9.5.3.5. China Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competitive Scenario
    • 9.5.4.3. Regulatory Scenario
    • 9.5.4.4. Reimbursement Scenario
    • 9.5.4.5. India Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Competitive Scenario
    • 9.5.5.3. Regulatory Scenario
    • 9.5.5.4. Reimbursement Scenario
    • 9.5.5.5. South Korea Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Australia
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Competitive Scenario
    • 9.5.6.3. Regulatory Scenario
    • 9.5.6.4. Reimbursement Scenario
    • 9.5.6.5. Australia Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.7. Thailand
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Competitive Scenario
    • 9.5.7.3. Regulatory Scenario
    • 9.5.7.4. Reimbursement Scenario
    • 9.5.7.5. Thailand Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competitive Scenario
    • 9.6.2.3. Regulatory Scenario
    • 9.6.2.4. Reimbursement Scenario
    • 9.6.2.5. Brazil Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competitive Scenario
    • 9.6.3.3. Regulatory Scenario
    • 9.6.3.4. Reimbursement Scenario
    • 9.6.3.5. Argentina Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.7. Middle East & Africa
  • 9.7.1. Middle East & Africa Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Regulatory Scenario
    • 9.7.2.4. Reimbursement Scenario
    • 9.7.2.5. South Africa Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Regulatory Scenario
    • 9.7.3.4. Reimbursement Scenario
    • 9.7.3.5. Saudi Arabia Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Regulatory Scenario
    • 9.7.4.4. Reimbursement Scenario
    • 9.7.4.5. UAE Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Competitive Scenario
    • 9.7.5.3. Regulatory Scenario
    • 9.7.5.4. Reimbursement Scenario
    • 9.7.5.5. Kuwait Lacrimal Cannula Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
  • 10.2.1. Innovators
• 10.3. Vendor Landscape
  • 10.3.1. List of key distributors and channel partners
  • 10.3.2. Key customers
• 10.4. Global Key company market share analysis, 2024
  • 10.4.1. BEAVER VISITEC INTERNATIONAL (TPG Capital)
    • 10.4.1.1. Company Overview
    • 10.4.1.2. Financial Performance
    • 10.4.1.3. Product Benchmarking
    • 10.4.1.4. Strategic Initiatives
  • 10.4.2. FCI
    • 10.4.2.1. Company Overview
    • 10.4.2.2. Financial Performance
    • 10.4.2.3. Product Benchmarking
    • 10.4.2.4. Strategic Initiatives
  • 10.4.3. Surtex Instruments Limited
    • 10.4.3.1. Company Overview
    • 10.4.3.2. Financial Performance
    • 10.4.3.3. Product Benchmarking
    • 10.4.3.4. Strategic Initiatives
  • 10.4.4. Madhu Instruments Pvt. Ltd.
    • 10.4.4.1. Company Overview
    • 10.4.4.2. Financial Performance
    • 10.4.4.3. Product Benchmarking
    • 10.4.4.4. Strategic Initiatives
  • 10.4.5. Microtrack Surgicals
    • 10.4.5.1. Company Overview
    • 10.4.5.2. Financial Performance
    • 10.4.5.3. Product Benchmarking
    • 10.4.5.4. Strategic Initiatives
  • 10.4.6. Corza Ophthalmology
    • 10.4.6.1. Company Overview
    • 10.4.6.2. Financial Performance
    • 10.4.6.3. Product Benchmarking
    • 10.4.6.4. Strategic Initiatives
  • 10.4.7. RUMEX International Co.
    • 10.4.7.1. Company Overview
    • 10.4.7.2. Financial Performance
    • 10.4.7.3. Product Benchmarking
    • 10.4.7.4. Strategic Initiatives
  • 10.4.8. Geuder
    • 10.4.8.1. Company Overview
    • 10.4.8.2. Financial Performance
    • 10.4.8.3. Product Benchmarking
    • 10.4.8.4. Strategic Initiatives
  • 10.4.9. EAGLE LABS (INNOVIA MEDICAL)
    • 10.4.9.1. Company Overview
    • 10.4.9.2. Financial Performance
    • 10.4.9.3. Product Benchmarking
    • 10.4.9.4. Strategic Initiatives
  • 10.4.10. Aspen Surgical Products, Inc. (Audax Private Equity)
    • 10.4.10.1. Company Overview
    • 10.4.10.2. Financial Performance
    • 10.4.10.3. Product Benchmarking
    • 10.4.10.4. Strategic Initiatives
  • 10.4.11. Sterimedix (Synergetics USA)
    • 10.4.11.1. Company Overview
    • 10.4.11.2. Financial Performance
    • 10.4.11.3. Product Benchmarking
    • 10.4.11.4. Strategic Initiatives
  • 10.4.12. Bausch + Lomb.
    • 10.4.12.1. Company Overview
    • 10.4.12.2. Financial Performance
    • 10.4.12.3. Product Benchmarking
    • 10.4.12.4. Strategic Initiatives
  • 10.4.13. Reea carewell products
    • 10.4.13.1. Company Overview
    • 10.4.13.2. Financial Performance
    • 10.4.13.3. Product Benchmarking
    • 10.4.13.4. Strategic Initiatives
  • 10.4.14. Tecfen Medical
    • 10.4.14.1. Company Overview
    • 10.4.14.2. Financial Performance
    • 10.4.14.3. Product Benchmarking
    • 10.4.14.4. Strategic Initiatives
• 10.5. Heat Map Analysis/ Company Market Position Analysis
• 10.6. Estimated Company Market Share Analysis, 2025
• 10.7. List of Other Key Market Players